OraSure Initiates Enrollment in Final Clinical Study for OraQuick(R) Rapid HIV Over-the-Counter Test
BETHLEHEM, Pa., Dec. 13, 2010 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its ...
In a first for the company, OraSure Technologies is teaming up with the Bill & Melinda Gates Foundation to offer its HIV self-testing product at a more affordable price in 50 developing countries in ...
OraSure Technologies’ HIV self-testing product has earned an important certification from the World Health Organization. The Bethlehem diagnostic testing and specimen collection company announced ...
Expansion of the OraQuick® HIV Self-Test to individuals aged 14 and older increases access to vital HIV testing for adolescents, addressing a significant public health need. The approval aligns with ...
There was a major victory in the battle against HIV/AIDS recently when the Food and Drug Administration approved the first easy-to-use “rapid” test for HIV, called OraQuick. This test provides results ...
The Test: The OraQuick Rapid HIV-1/2 Antibody Test was originally approved for use in whole blood in November 2002 and received a CLIA waiver for expanded use in this setting in January 2003. On March ...
The test stick is swabbed along the upper and lower gum once and placed into the test tube for 20 minutes before reading the results. The Food and Drug Administration (FDA) has expanded the approval ...
OraQuick HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick HIV ...
OraSure Technologies’ HIV self-testing product has earned an important certification from the World Health Organization. The Bethlehem diagnostic testing and specimen collection company announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback